Home
Conditions
Myelodysplastic Syndrome

Clinical trial condition

Myelodysplastic Syndrome

Explore clinical trials studying Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

440 public trials 66 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndrome trial results

Not yet recruiting

Peri-graft Cytokine Profile: Influence of Hematologic Disease and Donor Type

NCT07805746

Conditions: Acute Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: Not specified

View Trial Details

Not yet recruiting

Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome

NCT07780565

Conditions: Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not yet recruiting

Allogeneic iNKT Cell Therapy (agenT-797) After SCT

NCT07758218

Conditions: Acute Myeloid Leukemia, Allogenic Stem Cell Transplantation, Bone Marrow Diseases, +18 more
Locations: University of Wisconsin - Madison Madison, Wisconsin, United States

View Trial Details

Not yet recruiting

Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT07737769

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Not yet recruiting

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

NCT07254793

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia (AUL), +31 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Not yet recruiting

Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia

NCT07249476

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: CHU de Nantes Nantes, France

View Trial Details

Not yet recruiting

Study of an Innovative Therapy Using CAR-T Cells Targeting IL-1RAP in Patients With High-Risk Myelodysplastic Syndromes (MDS

NCT07455500

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Not specified

View Trial Details

Not yet recruiting

Selinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms Patients

NCT06900088

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China. Tianjin, China

View Trial Details

Active, not recruiting

Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

NCT04734990

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia-0, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia

NCT07052006

Conditions: Anemia in Myelodysplastic Syndromes, Bone Marrow Diseases, Hematologic Diseases, +3 more
Locations: Hemato Oncology Clinica Ahmedabad Pvt. Ltd. Vedanta Institute of Medical Sciences Ahmedabad, Gujarat, India

Shalby Hospital Ahmedabad, Gujarat, India

Malabar Cancer Center Kannur, Kerala, India

HCG Cancer Center Vizag Visakhapatnam, Krishna, India

View Trial Details

Myelodysplastic Syndrome

Myelodysplastic Syndrome trial results

Related conditions